Mario Gabelli Harmony Biosciences Holdings, Inc. Transaction History

Gamco Investors, Inc. Et Al

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$33.54 - $52.15 $150,930 - $234,675	-4,500 Reduced 31.47%	9,800 $478,000
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $473,902 - $731,159	14,300 New	14,300 $696,000

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.91B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.